Skip to main content

Table 2 Safety of the study regimens

From: Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

 

CC

CP

 

Grade 1-2

Grade 3-4

Grade 1-2

Grade 3-4

Anemia

30

6

38

5

Neutropenia

16

16

9

18

Thrombocytopenia

24

2

7

1

Fatigue

14

0

11

1

Myalgia

0

0

23

1

Anorexia

26

0

29

2

Nausea

21

1

18

1

Vomiting

8

1

4

0

Stomatitis

11

0

20

2

Diarrhea

8

1

11

1

Constipation

6

0

5

0

Neuropathy

13

0

26

0

Alopecia

1

0

10

0

Skin

15

0

16

1

Nail changes

6

0

8

0